Mink Therapeutics Investor Relations Material
Latest events
Q4 2024
Mink Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mink Therapeutics Inc
Access all reports
Mink Therapeutics Inc. is a biotechnology company that focuses on developing immunotherapy treatments. The company specializes in creating allogeneic, off-the-shelf therapies derived from invariant natural killer T (iNKT) cells. These therapies are designed to target cancer and other immune-related diseases. Mink Therapeutics’ approach aims to harness the natural immune response, offering potential treatments that enhance the body’s ability to fight diseases. The company is headquartered in New York, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
INKT
Country
🇺🇸 United States